Lv4
540 积分 2021-02-20 加入
新型β-内酰胺酶抑制剂复方制剂临床应用专家共识
2天前
已完结
Efficacy and Safety of AND017 for Treatment of Anemia in Dialysis-Dependent CKD
2个月前
已关闭
An update on the importance of plasma protein binding in drug discovery and development
5个月前
已完结
An update on the importance of plasma protein binding in drug discovery and development
6个月前
已完结
Cardiac and Kidney Adverse Effects of HIF Prolyl-Hydroxylase Inhibitors for Anemia in Patients With CKD Not Receiving Dialysis: A Systematic Review and Meta-analysis
7个月前
已完结
A novel scenario in the therapeutic management of anemia of chronic kidney disease: placement and use of roxadustat
7个月前
已完结
Pharmacokinetics, Pharmacodynamics, and Safety Evaluation of the Novel HIF-PH Inhibitor Enarodustat: An Open-Label Phase I Study in Healthy Chinese Participants
7个月前
已完结
The preclinical and phase 1 development of the novel oral cathepsin C inhibitor BI 1291583
8个月前
已关闭
A profile of brensocatib for non-cystic fibrosis bronchiectasis
8个月前
已完结
Comparing the pharmacokinetic and pharmacodynamic qualities of current and future therapies for uterine fibroids
9个月前
已完结
皖公网安备34019202002308
